1987
DOI: 10.1111/j.1432-1033.1987.tb11466.x
|View full text |Cite
|
Sign up to set email alerts
|

Primary structure of human thyroglobulin deduced from the sequence of its 8448-base complementary DNA

Abstract: The mRNA encoding human thyroglobulin has been cloned and sequenced. It is made up of a 8301-nucleotide segment encoding a preprotein monomer of 2767 amino acids, flanked by non-coding 5' and 3' regions of 41 and 106 nucleotides, respectively. This preprotein consists of a leader sequence of 19 amino acids, followed by the sequence of the mature monomer, corresponding to a polypeptide of 2748 amono acids ( M , = 302 773). On its amino-terminal side, 70% of the monomer is characterized by the presence of three … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

2
202
0
9

Year Published

1991
1991
2002
2002

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 311 publications
(213 citation statements)
references
References 33 publications
2
202
0
9
Order By: Relevance
“…Like EGP314 (Bergsagel et al, 1992;Bjork et al, 1993;Linnenbach et al, 1993;Perez and Walker, 1989;Strnad et al, 1989;Szala et al, 1990b) it is a type 1 transmembrane molecule with 12 conserved cystein residues and two N-glycosylation sites. Furthermore, an EGF-like domain and a thyroglobin-like repeat are conserved (Fornaro et al, 1995;Kiefer et al, 1991;Malthiery and Lissitzky, 1987). Also similar to EGP314 (Cooper et al, 1984;Fornaro et al, 1995), D5.7A has potential tyrosine phosphorylation sites.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Like EGP314 (Bergsagel et al, 1992;Bjork et al, 1993;Linnenbach et al, 1993;Perez and Walker, 1989;Strnad et al, 1989;Szala et al, 1990b) it is a type 1 transmembrane molecule with 12 conserved cystein residues and two N-glycosylation sites. Furthermore, an EGF-like domain and a thyroglobin-like repeat are conserved (Fornaro et al, 1995;Kiefer et al, 1991;Malthiery and Lissitzky, 1987). Also similar to EGP314 (Cooper et al, 1984;Fornaro et al, 1995), D5.7A has potential tyrosine phosphorylation sites.…”
Section: Discussionmentioning
confidence: 99%
“…Furthermore, it has been described for colon carcinoma cells (RemacleBonnet et al, 1997) that surface-bound plasmin induces selective proteolysis of IGF-binding protein-4 and thus, promotes autocrine IGF-II bio-availability. Taking into account that D5.7A/GA733 contains an IGF-binding domain homologous region (Fornaro et al, 1995;Kiefer et al, 1991;Malthiery and Lissitzky, 1987), a similar pathway of proteolytically induced accessibility is well conceivable. Thus, functional activity of D5.7A appears to depend largely on proteolytic cleavage of the molecule, which according to our ®ndings not only strengthens cell ± cell adhesion, but also provides a proliferative stimulus.…”
Section: Discussionmentioning
confidence: 99%
“…These features, however, did not aid in the identification of pathogenic T cell epitope sites by biochemical methods, as this was hampered by the large size of the molecule (homodimeric mass ϭ 660 kDa). In addition, previous T cell epitope mapping efforts could not avail themselves of the mouse Tg (mTg) gene sequence information and used either the human (14) or the partial rat (15) Tg sequence data in EAT studies, relying on the high sequence homology among Tg from different species. Despite these difficulties, over the last decade and via a variety of methods, five immunopathogenic Tg peptides have been identified, encompassing at least six distinct T cell epitopes (16).…”
mentioning
confidence: 99%
“…Thyroglobulin primers were custom designed according to the human thyroglobulin cDNA sequence reported by Malthiery and Lissitzky (1987) (Gene Bank accession number U93033). All primers were synthesized and purified by MWG-Biotech (Ebersberg, Germany).…”
Section: Oligonucleotide Primers and Probesmentioning
confidence: 99%